Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Novartis
NCT07654205 · Attention Deficit/Hyperactivity Disorder(ADHD), Alcohol Use
NCT07478458 · ADHD - Attention Deficit Disorder With Hyperactivity
NCT05842330 · ADHD
NCT07465081 · ADD/ADHD
NCT06810180 · Attention Deficit Hyperactivity Disorder (ADHD), Sleep, and more
Bayou City Research
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions